QuickView for lung neuroendocrine cell differentiation (biogroup)

1. L1000 CMAP - Embryonic kidney 293T cells with shRNA-mediated gene knockdown
2. L1000 CMAP Prostate cancer PC3 cells with gene overexpression perturbations (1 of 2)
3. L1000 CMAP - Breast carcinoma BT20 cells treated with small molecule perturbagens
4. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
5. L1000 CMAP Prostate cancer PC3 cells with gene overexpression perturbations (2 of 2)

There were no matches for lung neuroendocrine cell differentiation

1. RAD001 With Paclitaxel and Carboplatin in First Line Treatment of Patients With Advanced Large Cell …
2. Testing the Addition of an Anti-cancer Drug, BAY 1895344, to Usual Chemotherapy for Advanced Stage S…
3. Testing the Combination of XL184 (Cabozantinib), Nivolumab, and Ipilimumab for Poorly Differentiated…
4. KPT-330 to Treat Poorly Differentiated Lung and Gastroenteropancreatic Tumors
5. Study of Efficacy and Safety of PDR001 in Patients With Advanced or Metastatic, Well-differentiated,…